2 active not recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 2 |
Follow Leukemia, Lymphoid: new trials by email Literature Review of Leukemia, Lymphoid trials Research Report on Leukemia, Lymphoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hepatoprotective Measures for Children at High Risk of NAFLD Ursodeoxycholic Acid 250 Mg Oral Capsule, Omega -3 fatty acids, Physical exercise - Non Alcoholic Fatty Liver Diseases (NAFLD), Obesity and Overweight | Phase 4 | Active not recruiting | Ain Shams University | 200 | 2023-11-19 | 2025-04-09 |
| Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. Ibrutinib - Lymphoma, B-Cell, Lymphoma, Non-Hodgkin | Phase 4 | Active not recruiting | Pharmacyclics Switzerland GmbH | 297 | 2017-05-22 | 2025-10-30 |
Graft vs Host Disease (1) · Leukemia, B-Cell (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1) · Overweight (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Body Weight (1) · Digestive System Diseases (1) · Fatty Liver (1) · Liver Diseases (1) · Lymphoma (1)
Docosahexaenoic Acids (1) · Exercise (1) · Ursodeoxycholic Acid (1) · ibrutinib (1)
Ain Shams University (1) · Pharmacyclics Switzerland GmbH (1)
Australia (1) · Canada (1) · Czechia (1) · Egypt (1) · France (1) · Hungary (1) · Italy (1) · New Zealand (1) · Poland (1) · Russia (1) · South Korea (1) · Spain (1) · Sweden (1) · Taiwan (1) · Turkey (Türkiye) (1)
Fatma SE Ebeid, Professor of pediatrics (1) · Kevin Wu (1) · Manal H El-Sayed, Professor of pediatrics (1)
2016 (1)